Supplementary Figure S1 from Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial
Authors:
- Giampaolo BianchiniGiampaolo Bianchini
- Luca MalorniLuca Malorni
- Roberta CaputoRoberta Caputo
- Alberto ZambelliAlberto Zambelli
- Fabio PuglisiFabio Puglisi
- Giulia V. BianchiGiulia V. Bianchi
- Lucia Del MastroLucia Del Mastro
- Ida ParisIda Paris
- Filippo MontemurroFilippo Montemurro
- Marco ColleoniMarco Colleoni
- Giacomo AllegriniGAGiacomo Allegrini
- Stefano TamberiStefano Tamberi
Open Access
- 15 June 2026
- other
- Published by American Association for Cancer Research (AACR)